U.S. News Room
January 29, 2021
New Biomarker Analyses from Patritumab Deruxtecan Phase 1 Study in Patients with EGFR-Mutated NSCLC Presented at WCLC 2020
Download
January 29, 2021
Datopotamab Deruxtecan and ENHERTU® Show Promising Early Clinical Activity in Patients with Advanced Non-Small Cell Lung Cancer
Download
January 27, 2021
ENHERTU® Receives Prime Minister’s Award from the Japan Techno-Economics Society
Download
January 15, 2021
ENHERTU® Approved in the U.S. for the Treatment of Patients with Previously Treated HER2 Positive Advanced Gastric Cancer
Download